KR20030074461A - 나노여과에 의해서 단백질 용액으로부터 바이러스를 분리제거하는 방법 - Google Patents
나노여과에 의해서 단백질 용액으로부터 바이러스를 분리제거하는 방법 Download PDFInfo
- Publication number
- KR20030074461A KR20030074461A KR10-2003-0016027A KR20030016027A KR20030074461A KR 20030074461 A KR20030074461 A KR 20030074461A KR 20030016027 A KR20030016027 A KR 20030016027A KR 20030074461 A KR20030074461 A KR 20030074461A
- Authority
- KR
- South Korea
- Prior art keywords
- nanofiltration
- solution
- protein
- protein solution
- viruses
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/34—Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
- A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
- A61L2/0017—Filtration
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Water Supply & Treatment (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Separation Using Semi-Permeable Membranes (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
Claims (4)
- 아르기닌, 구아니딘, 시트룰린, 우레아 또는 이의 유도체로 이루어진 그룹으로부터의 카오트로픽 물질, 또는 폴리에톡시소르비탄 에스테르 그룹으로부터의 화합물을 단백질 분자의 응집을 감소시키거나 예방하기 위해서 나노여과에 앞서 단백질 용액에 부가하고, 이어서 용액을 15 내지 25nm의 세공 크기의 여과기를 통해 통과시키는 것을 특징으로 하는, 나노여과에 의해 단백질 용액으로부터 바이러스를 분리 제거하는 방법.
- 제1항에 있어서, 바이러스 분리가 피브리노겐 용액 또는 혈액 응고 인자의 용액에서 수행되는 것을 특징으로 하는 방법.
- 제1항 또는 제2항에 있어서, 나노여과를 실온에서 수행하는 것을 특징으로 하는 방법.
- 제1항 내지 제3항 중의 어느 한 항에 있어서, 나노여과 이외에 단백질 용액을 저온살균하는 것을 특징으로 하는 방법.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10211632.6 | 2002-03-15 | ||
DE10211632A DE10211632A1 (de) | 2002-03-15 | 2002-03-15 | Verfahren zur Abtrennung von Viren aus einer Proteinlösung durch Nanofiltration |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20030074461A true KR20030074461A (ko) | 2003-09-19 |
KR100998158B1 KR100998158B1 (ko) | 2010-12-06 |
Family
ID=7714123
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020030016027A KR100998158B1 (ko) | 2002-03-15 | 2003-03-14 | 나노여과에 의해서 단백질 용액으로부터 바이러스를 분리제거하는 방법 |
Country Status (10)
Country | Link |
---|---|
US (1) | US7919592B2 (ko) |
EP (1) | EP1348445B1 (ko) |
JP (1) | JP4495404B2 (ko) |
KR (1) | KR100998158B1 (ko) |
AU (1) | AU2003200981B2 (ko) |
CA (1) | CA2421681C (ko) |
DE (1) | DE10211632A1 (ko) |
DK (1) | DK1348445T3 (ko) |
ES (1) | ES2410155T3 (ko) |
NO (1) | NO326670B1 (ko) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AT501088A2 (de) * | 2002-12-18 | 2006-06-15 | Bio Prod & Bio Eng Ag | Stabile therapeutische proteine |
ES2214967B1 (es) * | 2003-03-06 | 2005-06-16 | Probitas Pharma, S.A | Procedimiento para la eliminacion de virus en soluciones de fibrinogeno y fibrinogeno obtenido por dicho procedimiento. |
FR2861395B1 (fr) | 2003-10-23 | 2006-02-17 | Lab Francais Du Fractionnement | Facteur viii viralement securise a faible teneur en multimeres superieurs |
AU2004294403A1 (en) | 2003-12-01 | 2005-06-16 | Novo Nordisk Health Care Ag | Nanofiltration of factor VII solutions to remove virus |
FR2866890B1 (fr) * | 2004-02-27 | 2008-04-04 | Lab Francais Du Fractionnement | Procede de purification d'albumine comprenant une etape de nanofiltration, solution et composition a usage therapeutique la contenant |
GB0413630D0 (en) * | 2004-06-18 | 2004-07-21 | Avecia Ltd | Process |
WO2006042541A1 (en) | 2004-10-21 | 2006-04-27 | Statens Serum Institut | A method comprising nanofiltration to obtain an mbl product safe from infectious agents and the product obtainable by this method |
FR2887883B1 (fr) | 2005-06-29 | 2007-08-31 | Lab Francais Du Fractionnement | Procede de separation des proteines fibrinogene, facteur xiii et colle biologique d'une fraction plasmatique solubilisee et de preparation de concentres lyophilises desdites proteines |
ES2257225B1 (es) * | 2006-02-17 | 2007-03-16 | Grifols, S.A | Preparacion terapeutica de fviia de muy alta pureza y metodo para su obtencion. |
US20090186395A1 (en) * | 2006-06-26 | 2009-07-23 | Israel Nur | Virus Removal by Nanofiltration |
CN101489655A (zh) | 2006-07-14 | 2009-07-22 | 威斯康星旧生研究基金会 | 捕获病毒用吸附膜 |
CN102119168A (zh) * | 2008-06-03 | 2011-07-06 | 帕特里有限公司 | 抗体纯化工艺 |
ES2573663T5 (es) | 2009-03-27 | 2019-12-12 | Asahi Kasei Medical Co Ltd | Procedimiento para eliminar virus de una solución de anticuerpos monoclonales de concentración elevada |
US9371355B2 (en) | 2010-09-20 | 2016-06-21 | Octapharma Ag | Process for production of fibrinogen |
ES2641042T3 (es) | 2011-06-24 | 2017-11-07 | Asahi Kasei Kuraray Medical Co., Ltd. | Procedimiento para la fabricación de un fármaco proteínico |
CN104321340B (zh) | 2012-03-13 | 2018-11-09 | 欧克塔医药公司 | 用于生产纤维蛋白原的改进工艺及其生产的纤维蛋白原 |
CN104968676A (zh) | 2012-10-03 | 2015-10-07 | 美国杰特贝林生物制品有限公司 | 一种纯化蛋白质的方法 |
US9534029B2 (en) | 2012-10-03 | 2017-01-03 | Csl Behring Ag | Method of purifying proteins |
US20140154233A1 (en) | 2012-12-05 | 2014-06-05 | Csl Limited | Method of purifying therapeutic proteins |
US10188965B2 (en) | 2012-12-05 | 2019-01-29 | Csl Behring Gmbh | Hydrophobic charge induction chromatographic depletion of a protein from a solution |
EP3418290A1 (en) | 2013-08-08 | 2018-12-26 | CSL Ltd. | Contaminant removal method |
CN110997015A (zh) * | 2017-08-23 | 2020-04-10 | 德国杰特贝林生物制品有限公司 | 用于von Willebrand因子的病毒过滤的方法 |
FR3090321B1 (fr) * | 2018-12-21 | 2023-07-14 | Lab Francais Du Fractionnement | Procédé de filtration du fibrinogène |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6096872A (en) * | 1997-10-14 | 2000-08-01 | Ortho Diagnostic Systems, Inc. | Viral clearance process |
US5981254A (en) * | 1997-10-30 | 1999-11-09 | Haemacure Corporation | Process for producing thrombin from plasma |
FR2772381B1 (fr) * | 1997-12-15 | 2001-06-08 | Lab Francais Du Fractionnement | Procede de preparation par filtration d'une solution de facteur viii securisee viralement |
FI106465B (fi) * | 1998-06-10 | 2001-02-15 | Suomen Punainen Risti Veripalv | Menetelmä virusturvallisten farmaseuttisten koostumusten valmistamiseksi |
US6447774B1 (en) * | 1998-11-18 | 2002-09-10 | Aventis Behring Gmbh | Stabilized protein preparations for a tissue adhesive |
US7276235B2 (en) | 1998-11-18 | 2007-10-02 | Zlb Behring Gmbh | Tissue glue with improved antiadhesive properties |
KR20020063597A (ko) * | 1999-12-20 | 2002-08-03 | 미츠비시 웰파마 가부시키가이샤 | 다공성막으로 처리되어 바이러스가 제거된 혈장 단백질조성물 및 그 제조 방법 |
DE10012732A1 (de) * | 2000-03-18 | 2001-09-20 | Aventis Behring Gmbh | Thrombin-Zubereitungen und Verfahren zu ihrer Herstellung |
DE10022092A1 (de) * | 2000-05-08 | 2001-11-15 | Aventis Behring Gmbh | Stabilisiertes Protein-Präparat und Verfahren zu seiner Herstellung |
-
2002
- 2002-03-15 DE DE10211632A patent/DE10211632A1/de not_active Withdrawn
-
2003
- 2003-02-18 ES ES03003632T patent/ES2410155T3/es not_active Expired - Lifetime
- 2003-02-18 EP EP03003632.1A patent/EP1348445B1/de not_active Expired - Lifetime
- 2003-02-18 DK DK03003632.1T patent/DK1348445T3/da active
- 2003-03-07 NO NO20031066A patent/NO326670B1/no not_active IP Right Cessation
- 2003-03-12 CA CA2421681A patent/CA2421681C/en not_active Expired - Lifetime
- 2003-03-13 AU AU2003200981A patent/AU2003200981B2/en not_active Expired
- 2003-03-13 US US10/386,486 patent/US7919592B2/en not_active Expired - Fee Related
- 2003-03-14 JP JP2003069923A patent/JP4495404B2/ja not_active Expired - Lifetime
- 2003-03-14 KR KR1020030016027A patent/KR100998158B1/ko active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
CA2421681A1 (en) | 2003-09-15 |
NO20031066L (no) | 2003-09-16 |
AU2003200981A1 (en) | 2003-10-02 |
EP1348445B1 (de) | 2013-04-10 |
US20030232969A1 (en) | 2003-12-18 |
KR100998158B1 (ko) | 2010-12-06 |
NO20031066D0 (no) | 2003-03-07 |
US7919592B2 (en) | 2011-04-05 |
ES2410155T3 (es) | 2013-07-01 |
JP2003274941A (ja) | 2003-09-30 |
EP1348445A1 (de) | 2003-10-01 |
CA2421681C (en) | 2012-01-03 |
NO326670B1 (no) | 2009-01-26 |
AU2003200981B2 (en) | 2008-11-20 |
DK1348445T3 (da) | 2013-07-01 |
DE10211632A1 (de) | 2003-10-09 |
JP4495404B2 (ja) | 2010-07-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100998158B1 (ko) | 나노여과에 의해서 단백질 용액으로부터 바이러스를 분리제거하는 방법 | |
JP5105734B2 (ja) | 安定性トロンビン組成物 | |
CA2645701C (en) | Process for obtaining a concentrate of von willebrand factor or a complex of factor viii/von willebrand factor and use of the same | |
JP4808864B2 (ja) | ウイルスの不活化方法 | |
JP4979571B2 (ja) | ナノ濾過工程を含むアルブミン精製方法、それを含有する治療用途のための溶液及び組成物 | |
WO2010109920A1 (ja) | 高濃度モノクローナル抗体溶液中のウイルス除去方法 | |
JP2004269529A (ja) | フィブリノゲン溶液中のウイルスを除去する方法およびこの方法により得られるフィブリノゲン | |
ES2237854T5 (es) | Procedimiento para la preparación mediante filtración de una solución de factor VIII víricamente segura | |
CA2394797A1 (en) | Process for producing virus-free plasma protein composition by porous membrane treatment, virus-free plasma protein composition and method of removing viruses | |
JP4222871B2 (ja) | ノンエンベロープウイルス凝集条件下での濾過によるノンエンベロープウイルスの除去方法 | |
JP2004277323A (ja) | フィブリノーゲン含有溶液のウイルス除去法 | |
WO2007054297A2 (de) | Verwendung hydrophober interaktionschromatographie zur virusabreichung | |
FR3090321A1 (fr) | Procédé de filtration du fibrinogène | |
KR100451308B1 (ko) | 단백질 의약품 정제 방법에서의 바이러스 제거 방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20131101 Year of fee payment: 4 |
|
FPAY | Annual fee payment |
Payment date: 20141103 Year of fee payment: 5 |
|
FPAY | Annual fee payment |
Payment date: 20151030 Year of fee payment: 6 |
|
FPAY | Annual fee payment |
Payment date: 20161028 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20171027 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20191029 Year of fee payment: 10 |